Reader Comments
Post a new comment on this article
Post Your Discussion Comment
Please follow our guidelines for comments and review our competing interests policy. Comments that do not conform to our guidelines will be promptly removed and the user account disabled. The following must be avoided:
- Remarks that could be interpreted as allegations of misconduct
- Unsupported assertions or statements
- Inflammatory or insulting language
Thank You!
Thank you for taking the time to flag this posting; we review flagged postings on a regular basis.
closeErrors
Posted by mel-jade on 26 Jun 2017 at 18:56 GMT
The manuscript contains multiple errors in spelling and syntex that seem to be caused by a severe formatting problem:
Introduction
- Page 2, Paragraph 1, Lines 5-7:
Error: “βtermed “erm” cleave the βhe ave “ermed “es termed “myes termethereby prevent their interference with the transpeptidase activity of the tidase ase h hydrolysis and.
Correction: “β-lactamases” cleave the β-lactam ring through hydrolysis and thereby prevent their interference with the transpeptidase activity of the “penicillin-binding proteins”.
- Page 2, Paragraph 1, Lines 7-8:
Error: " \o "Witte W, 20
Correction: β-lactamase genes
- Page 2, Paragraph 1, Line 13:
Error: esistance ncoding on
Correction: β-lactam antibiotics
- Page 3, Paragraph 1, Line 1:
Error: ßrom pTM
Correction: βLACTATM
- Page 3, Paragraph 1, Lines 2-3:
Error: mogenic cephalos- porine in n in sion in d-spectrum-beta-lactamase, AmpC, and Carbapenemase issues<linases
Correction: ß-lactamases that confer resistance to 3GC. Notably, HMRZ-86 is not hydrolyzed by acquired penicillinases
Material and Methods: Page 3, section " Susceptibility testing and detection of ESBL-E "
- Paragraph 1, Line 1:
Error: (bioMK2 (bi S.A., NS.A., Nu, Germany)
Correction: (bioMérieux S.A., Nürtingen, Germany)
- Paragraph 2, Line 2:
Error: , bioMoMD on S.A., Nuertingen,Germany)
Correction: (bioMérieux S.A., Nürtingen, Germany)
- Paragraph 2, Lines 2-3:
Error: (bioMioMivx S. A., NS.A., NN, Germany)
Correction: (bioMérieux S.A., Nürtingen, Germany)
- Paragraph 2, Line 5:
Error: manufactureridelberg, Ge
Correction: manufacturer´s protocol
- Paragraph 3, Lines 4-5:
Error: (SensoQuest GmbH, GGmbH, Gs, Germany)
Correction: (SensoQuest GmbH, Göttingen, Germany)
- Paragraph 3, Lines 1,3,6:
Error: at three different places ® is followed by single letters such as l, e and e
Correction: ® only
- Paragraph 4, Lines 2-3:
Error: AmpC&ESβmpC&EScreen ESBL activCefpodoxim ESpo- doxim ESESBL activity was conDiagnostica GmbH) and E-Test ESBL from bioMH) and S.A.
Correction: AmpC&ESβL Detection Discs and Cefpodoxim ESβL ID Disc Set (both from Mast Diagnostica GmbH) and E-Test ESBL from bioMérieux S.A..
Discussion
- Page 10, Paragraph 3, Lines 11-12:
Error: tor of ESBLPseudomonas aeruginosa isolates
Correction: resistant Pseudomonas aeruginosa isolates